Results
Assessment of the relative binding revealed that 86% (69/ 80) of the plasma were able to reach an IC50 binding titer with consensus-B V3 peptide with substantially low antibody titers compared to binding with consensus-C V3 (mean IC50 V3-C=12611 versus V3-B=2736) (p<0.0001), implying that although majority of the antibodies were subtype specific, a good proportion of cross reactive anti-V3 antibodies also exist in these plasma (range=1-97%, mean=23%). We observed a strong correlation between percent cross reactive anti-V3 antibodies and days from first diagnosis (n=80: r=0.29 p=0.008) while no such association was found with other clinical and immunological parameters like plasma viral load (n=53: r=0.16 p=0.24), CD4 count (n=80: r=0.10 p=0.34), total plasma IgG levels (n=65: r=-0.09 p=0.45) and eventually with the V3 sequence of donor viruses.
Conclusion
This is the first study to demonstrate the presence of cross-clade reactive anti-V3 antibodies and their association with time in the plasma of HIV-1 infected Asian Indians from north India.
